Clinical Trial Update: Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy of nilotinib in pigmented villonodular synovitis and tenosynovial giant cell tumor; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pigmented Villonodular Synovitis
• Tenosynovial Giant Cell Tumor

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Centre Leon Berard | Conditions: Pigmented Villonodular Synovitis | Phase 2 | Status: COMPLETED